Recruiting Prurigo Nodularis Studies in Columbus
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
A Phase 2a, randomized, double-blind, placebo-controlled, multiple ascending dose study in patients who are hospitalized with presumed pneumonia requiring supplemental oxygen therapy. The purpose of t...
About Prurigo Nodularis Clinical Trials in Columbus
Prurigo nodularis is a chronic skin condition characterized by intensely itchy, hard lumps on the skin that develop from repeated scratching. It significantly impacts quality of life and sleep. Treatment includes topical therapies, phototherapy, and newer targeted biologics.
There are currently 2 prurigo nodularis clinical trials recruiting participants in Columbus, INDIANA. These studies are seeking a combined 20,120 participants. Research is being sponsored by UMC Utrecht, Vasomune Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prurigo Nodularis Clinical Trials in Columbus — FAQ
Are there prurigo nodularis clinical trials in Columbus?
Yes, there are 2 prurigo nodularis clinical trials currently recruiting in Columbus, INDIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbus?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbus research site will contact you about next steps.
Are clinical trials in Columbus free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbus studies also compensate for your time and travel.
What prurigo nodularis treatments are being tested?
The 2 active trials in Columbus are testing new therapies including novel drugs, biologics, and treatment approaches for prurigo nodularis.
Data updated March 2, 2026 from ClinicalTrials.gov